Characteristics of patients with hematologic malignancies without seroconversion post-COVID-19 third vaccine dosing.

S. Hallmeyer,M. A. Thompson,V. Fitzpatrick,Y. L. Liao,M. P. Mullane,S. C. Medlin,K. Copeland,J. L. Weese

Biology methods & protocols（2023）

引用 0|浏览17

暂无评分

摘要

This study focuses on an important subset of patients with HM who are not seroconverting after the COVID mRNA 3V. This gain in scientific knowledge is needed for clinicians to target and counsel these vulnerable patients.

查看译文

关键词

COVID-19,SARS-CoV-2 mRNA vaccine,hematologic malignancies,vaccine

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要